HLB Pharmaceutical Co., Ltd. (KOSDAQ: 047920)
South Korea flag South Korea · Delayed Price · Currency is KRW
23,200
-200 (-0.85%)
Dec 19, 2024, 3:00 PM KST

HLB Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2019 FY 2018 FY 2017
Period Ending
Dec '24 Dec '19 Dec '18 Dec '17
Market Capitalization
320,16475,19458,50780,206
Market Cap Growth
28.52%28.52%-27.05%-
Enterprise Value
77,59577,59562,071-
Last Close Price
22800.005430.004225.006420.00
PE Ratio
677.37159.09--
PS Ratio
8.752.082.855.16
PB Ratio
17.644.203.444.77
P/TBV Ratio
4.314.313.504.83
P/OCF Ratio
55.5655.56--
EV/Sales Ratio
2.152.153.02-
EV/EBITDA Ratio
25.1925.19--
EV/EBIT Ratio
53.8553.85--
Debt / Equity Ratio
0.740.740.450.89
Debt / EBITDA Ratio
4.284.28--
Asset Turnover
0.880.880.54-
Inventory Turnover
3.273.273.13-
Quick Ratio
1.011.010.941.01
Current Ratio
1.261.261.311.31
Return on Equity (ROE)
2.71%2.71%-41.77%-
Return on Assets (ROA)
2.19%2.19%-9.55%-
Return on Capital (ROIC)
3.23%3.23%-12.90%-
Earnings Yield
0.15%0.63%-12.07%-6.79%
FCF Yield
-0.01%-0.06%-4.91%-3.77%
Buyback Yield / Dilution
-2.30%-2.30%-13.08%-
Total Shareholder Return
-2.30%-2.30%-13.08%-
Source: S&P Capital IQ. Standard template. Financial Sources.